LEO 90100 in the Treatment of Psoriasis Vulgaris

Trial Profile

LEO 90100 in the Treatment of Psoriasis Vulgaris

Phase of Trial: Phase II

Latest Information Update: 30 Jul 2018

At a glance

  • Drugs Betamethasone-dipropionate/calcipotriol (Primary) ; Betamethasone; Calcipotriol
  • Indications Plaque psoriasis
  • Focus Therapeutic Use
  • Sponsors LEO Pharma
  • Most Recent Events

    • 24 Mar 2015 Results presented at the 73rd Annual Meeting of the American Academy of Dermatology.
    • 04 Sep 2012 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 01 Mar 2012 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top